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Abstract: We used the retroviral vector PINCO
[which expresses the green fluorescent protein
(GFP) as a selectable marker], to infect growth
factor-dependent immature D1 dendritic cells (DC).
The efficiency of infection in different experiments
was between 5 and 30%, but subsequent cell
sorting led to a virtually homogeneous population
of GFP-positive cells. Retroviral infection did not
modify the immature DC phenotype, as shown by
the low expression of major histocompatibility
complex and co-stimulatory molecules. Further-
more, the GFP-positive D1 cells underwent full
maturation after lipopolysaccharide treatment, as
indicated by a high expression of cell-surface MHC
and co-stimulatory molecules, and also by strong
stimulatory activity in allogeneic mixed lymphocyte
reaction. The high efficiency of this retroviral
system, the rapidity of the technique, and the
possibility to overcome in vitro selection make this
method very attractive for the stable introduction
of heterologous genes into proliferating immature
mouse D1 cells. Furthermore, this approach is
suitable for functional studies of new DC-specific
genes involved in DC maturation and survival. J.
Leukoc. Biol. 66: 263–267; 1999.
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INTRODUCTION
Dendritic cells (DC) are highly potent antigen-presenting cells
capable of inducing a primary T lymphocyte response [1].
These bone marrow-derived leukocytes are widely distributed
in tissues, especially in those with an environmental interface
(skin and mucosal membranes) and in lymphoid organs. They
express a unique repertoire of surface molecules involved in the
uptake of microorganisms or their products. Because pattern
recognition receptors, such as the Toll-like molecules [2], have
recently been described as lipopolysaccharide (LPS) receptors
[3, 4] these molecules are likely to be involved in microbial
uptake. Once activated by inflammatory stimuli and infectious
agents, DC migrate to the lymphoid organs to interact with
antigen-specific T cells. During migration, the immature DC
acquire professional antigen-presenting capacity, translocate
major histocompatibility complex (MHC) molecules to the cell
surface, and up-regulate co-stimulatory molecules [4]. As
mature DC, they direct both the quality and the quantity of the
immune response, providing all the signals for the activation of
unprimed T cells [1].
Several groups have generated large numbers of functional
DC/Langerhans cells from the precursors in either bone
marrow, cord blood, or peripheral blood. DC precursors have
been isolated with granulocyte-macrophage colony-stimulating
factor (GM-CSF) alone or in combination with other cytokines
[6–12]. However, such DC could only be propagated for limited
periods because in vitro these cells undergo spontaneous
maturation and cell death.
We have previously described a DC culture system that
allows the propagation of homogeneous immature mouse DC
that are growth factor-dependent and that remain immature in
the presence of the conditioned medium DC-GM [5, 13]. This
long-term, growth factor-dependent immature D1 cell line can
be fully matured in response to inflammatory signals or
bacteria, mimicking the in vivo DC maturation process. Using
this unique differentiation system, the coordinated molecular
events and the kinetics of DC maturation have been studied
[14, 15, F. Granucci et al. unpublished results, and M. Foti et
al. unpublished results].
We report the use of the recently described retroviral vector
PINCO [16] to genetically modify the immature D1 cells
without altering their morphological and functional properties.
The characteristics of the PINCO vector (modified from the
original plasmid LZRSpBMN-Z [17]) are the presence of the
Epstein Barr virus origin of replication, and the EBNA1 gene
outside the long terminal repeats (LTRs). This confers stable
episomal maintenance of the retroviral constructs within the
packaging cell line. In addition, the vector contains the gene
encoding the green fluorescent protein (GFP) driven by a
cytomegalovirus promoter and a cloning site for heterologous
gene insertion driven by the 58 LTR. Transient transfection of
Abbreviations: GFP, green fluorescent protein; LPS, lipopolysaccharide;
MHC, major histocompatibility complex; MLR, mixed lymphocyte reaction;
DC, dendritic cell; GM-CSF, granulocyte-macrophage colony-stimulating fac-
tor; IMDM, Iscove’s modified Dulbecco’s medium; PBS, phosphate-buffered
saline.
Correspondence: Paola Ricciardi Castagnoli, CNR Center of Molecular and
Cellular Pharmacology, University of Milano, 20129 Milano, Italy. E-mail:
Paola@farma8.csfic.mi.cnr.it
Received February 10, 1999; revised March 27, 1999; accepted March 30,
1999.
Journal of Leukocyte Biology Volume 66, August 1999 263
the PINCO vector in the amphotropic packaging cell line,
Phoenix, results in high-titer production of retroviral particles.
Furthermore, it has been shown that this group of vectors is not
prone to rearrangements, when maintained episomally in the
packaging cells, and that viral stocks are helper-virus free [17].
Using this system, we have obtained a virtually homogeneous
population of GFP-positive mouse DC that preserve their
immature phenotype after retroviral infection. Moreover, the
transduced cells are still able to undergo both functional and
phenotypical maturation in response to lipopolysaccharide
(LPS) or bacteria. The ability to insert and express heterologous
genes with high efficiency in immature DC is full of promise for




The D1 cells were derived from murine splenic DC and maintained in vitro as
growth factor-dependent DC [5]. D1 cells were grown in complete Iscove’s
modified Dulbecco’s medium (IMDM) supplemented with 30% of DC-GM, as
described [13].
LPS (Escherichia coli serotype 026:B6) was purchased from Sigma Chemi-
cals.
Retroviral infection of DC
The PINCO vector used in this study encodes the enhanced GFP under the
transcriptional control of a cytomegalovirus promoter. The generation of
retroviral vector and the production of high-titer vectors have been previously
described [16]. To infect D1 cells, the cells were cultured in the presence of
viral supernatant (filtered with a 0.45-µm filter) supplemented with 4 µg/mL of
polybrene (Sigma) for 3 h. Three infection cycles were performed. After
infection, the D1 cells were plated in complete IMDM supplemented with 30%
of DC-GM for 24 h. The efficiency of transduction was then evaluated by FACS
analysis (see below) and by fluorescence microscopy. Infected D1 cells were
grown for 1 day on glass cover slips, fixed with 4% paraformaldehyde, and
observed with a fluorescence microscope.
Sorting of GFP-positive cells
Infected cells were sorted by a FACScan (FACS-Vantage; Becton-Dickinson,
Mountain View, CA) following the standard procedure with a standard
excitation wavelength of 488 nm.
Phenotypical maturation
Twenty-four hours after LPS (10 µg/mL) activation, the D1 cells were detached
with 2 mM EDTA in phosphate-buffered saline (PBS) and incubated with one of
the following mAb: PE-conjugated anti-MHC II (I-Ad/I-Ed), biotinylated
anti-CD86 (B7.2), PE-conjugated anti-CD40 (PharMingen). Appropriately
diluted PE-streptavidin was used to detect the binding of biotinylated mAb.
To block Fc receptor binding, staining was carried out in the presence of
2-4G2 (anti-CD32) antibody. The cells were washed and analyzed using the
FACScan (Becton-Dickinson).
Mixed lymphocyte reaction (MLR) assay
Primary allogeneic MLR was set up with sorted GFP-positive DC as stimula-
tors. Stimulator cells were treated with mitomycin C (50 µg/mL, 20 min at 37°C;
Sigma) and co-cultured with 2 3 105 BALB/c lymph node cells/well in 200 µL
of complete IMDM. Cultures were pulsed on day 3 with 1 µCi/well of
[3H]thymidine (specific activity 85 Ci/mmol); Amersham, Amersham Place,
UK). Incorporation of [3H]thymidine was measured 8 h later with a liquid
scintillation counter (MicroBeta Plus; Wallac, Turku, Finland). Each point on
the graph represents the mean count per minute from triplicate cultures.
RESULTS
Infection of D1 cells
The packaging cell line Phoenix was transfected with the
PINCO vector (Fig. 1) by the calcium-phosphate chloroquine
method. Culture supernatants containing viral particles were
collected 48 h after transfection. Infection was performed by
culturing D1 cells with viral supernatant for 3 h. Three
infection cycles were performed. The percentage of transduced
cells was evaluated by FACS analysis 24 h after the last
infection. The efficiency of transduction in different experi-
ments was between 5 and 30%. The infected population was
viable and dividing actively. Two days later the infected cells
were sorted on the basis of GFP expression. A population of
97% GFP-positive cells was thus obtained (Fig. 2).
Phenotypical maturation of D1/GFP
The GFP-positive DC population (D1/GFP) was studied for its
phenotypical and differentiative properties and compared with
the non-transduced D1 cells.
The D1/GFP cells had a morphology comparable to the
noninfected cells. The GFP expression resulted in a diffuse
cytoplasmic fluorescent pattern in both fixed and living cells
(Fig. 3).
Fig. 1. PINCO vector. This plasmid contains the full-length Moloney LTRs
and the extended c sequence and carries the GFP cDNA under the control of
the cytomegalovirus (CMV) promoter. Outside the LTRs, it contains the PGK-1
promoter that drives puromycin resistance, the EBV origin of replication, and
the EBNA-1 gene. The last two endow the plasmid with the capacity to replicate
as an episome and develop 5–20 copies/mammalian cell. In 58 to the CMV
promoter there are cloning sites for the insertion of the cDNAs.
Fig. 2. D1 cells were infected with the PINCO vector. GFP expression before
(left panel) and after (right panel) FACS sorting.
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The D1 cells are maintained in an immature state in the
presence of the conditioned medium (DC-GM). Various activat-
ing signals such as living bacteria or LPS promote their full
maturation. During this process MHC class II molecules are
translocated to the cell surface, adhesion/costimulation mol-
ecules are up-regulated, the actin-based cytoskeleton is rear-
ranged, and cell motility is increased. After cell sorting, the
pattern of the expression of surface molecules in the GFP-
positive population was investigated by FACS analysis. The
expression of MHC class II, B7.2, and CD40 was comparable in
the infected and in the non-infected population.
To test whether retroviral infection altered the capacity of DC
to mature, we induced the maturation of the sorted D1 cells.
Cells were cultured for 24 h in the presence of LPS (10 µg/mL)
and then the expression of the surface molecules was analyzed
by FACS. The shift in the expression patterns of MHC class II
molecules, B7.2 and CD40, was comparable in both the
GFP/D1 and in the noninfected D1 cells (Fig. 4). In conclu-
sion, retroviruses do not induce DC maturation.
Functional maturation of D1/GFP
To investigate whether retroviral infection altered the ability of
mature DC to stimulate unprimed T cells, the sorted GFP-
positive D1 population was activated with LPS and used as a
stimulator of unprimed BALB/c lymph node T lymphocytes.
Consistent with a well-known property of DC, the GFP-D1 cells
developed strong stimulatory activity after maturation induced
by LPS (Fig. 5). This result further indicates that the infected
D1/GFP maintain their immature phenotype and are still
susceptible to fully functional maturation.
DISCUSSION
Several transfection methods to introduce heterologous genes
into DC have been described, including DNA liposome com-
plexes, electroporation, and CaPO4 precipitation [18]. Neverthe-
less, the efficiency of these methods, when applied to DC, has
always been very low. In contrast, retroviral vectors have been
successfully used to introduce genetic information into the
chromosomal DNA of DC progenitors. The limitation of this
system is the requirement of proliferating DC or DC progenitors
for stable integration of the retroviral constructs. For this
reason, the current approach is to infect the actively proliferat-
ing hematopoietic progenitor cells (CD341) and then to differen-
tiate the infected cells in vitro to mature DC [19–24]. However,
these cells can survive for only a few days due to their in vitro
spontaneous maturation.
Fig. 3. To detect the expression of GFP, the infected cells were grown directly on coverslip, fixed with 3% paraformaldehyde, and observed using a fluorescence
microscope (A, phase contrast; B, GFP fluorescence).
Fig. 4. Surface marker expression on D1
cells. Open histograms represent the ex-
pression in the immature D1 population,
dotted histograms represent the expres-
sion in the mature population after LPS
treatment, filled histograms represent the
isotype control.
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In contrast, in the mouse system, we could take advantage of
a method that allows the production of growth factor-dependent,
immature DC (named D1 cells) that indefinitely proliferate in
vitro.
Using the PINCO vector carrying GFP as a selectable
marker, the D1 cells were easily infected and selected. Genes
for drug resistance have been extensively used to detect
transduced cells, but positive selection of the modified cells is
only possible after several weeks of culture. Alternative
strategies are based on the use of heterologous genes coding for
proteins that can be further detected by incubation with the
appropriate fluorescin-labeled antibodies. However, the detec-
tion of such gene products is time-consuming and is prone to
cellular toxicity or DC maturation [25]. In contrast, GFP-based
selection has a number of advantages: the GFP expression does
not influence the immature DC phenotype and it can be
detected after a short time, thus allowing rapid flow cytometry
sorting and quantification of the transduced cells. The infection
and selection of D1 cells can be carried out in 2 days.
The high efficiency of this retroviral system, the rapidity of
the technique, and the possibility of overcoming in vitro
selection render this method very attractive for the stable
introduction of heterologous genes into proliferating immature
mouse D1 cells. Furthermore, this approach is suitable for
functional studies of new DC-specific genes involved in DC
maturation and survival.
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